methamphetamine has been researched along with Clerambault Syndrome in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 6 (54.55) | 2.80 |
| Authors | Studies |
|---|---|
| Fattakhov, N; Park, M; Stangis, M; Toborek, M; Torices, S | 1 |
| Liu, J; Reiner, B; Xiong, H; Xu, L; Zheng, Y | 1 |
| Athota, P; Guda, C; Jagadesan, S; Nguyen, NM; Pendyala, G; Schaal, VL; Yelamanchili, SV | 1 |
| Geyer, MA; Grant, I; Heaton, RK; Letendre, S; MacQueen, DA; Minassian, A; Perry, W; Pocuca, N; Young, JW | 1 |
| Cherner, M; Fields, JA; Grant, I; Iudicello, JE; Kaul, M; Letendre, SL; Marcondes, MCG; Saloner, R; von Känel, S | 1 |
| Berman, JW; Ciborowski, PS; Emanuel, K; Fox, HS; Gaskill, PJ; Lamberty, BG; León-Rivera, R; Matt, SM; Morsey, B; Niu, M; Yu, F | 1 |
| Chen, CK; Chen, YC; Lin, SK; Wang, LJ | 1 |
| Achim, CL; Day, TR; Mehta, SR; Moore, DJ; Pérez-Santiago, J; Smith, DM; Soontornniyomkij, V; Var, SR; Vitomirov, A | 1 |
| Miyamoto, K | 1 |
| Hada, H; Miyamoto, K | 1 |
| Ban, TA; Kral, VA; Lehmann, HE; Silver, D | 1 |
2 review(s) available for methamphetamine and Clerambault Syndrome
| Article | Year |
|---|---|
Synergistic Impairment of the Neurovascular Unit by HIV-1 Infection and Methamphetamine Use: Implications for HIV-1-Associated Neurocognitive Disorders.
Topics: AIDS Dementia Complex; Amphetamine-Related Disorders; Animals; Blood-Brain Barrier; Comorbidity; HIV Infections; Humans; Mental Processes; Methamphetamine; Neurocognitive Disorders; Neuroinflammatory Diseases | 2021 |
Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior.
Topics: Amphetamine-Related Disorders; Animals; Blood-Brain Barrier; Brain; Cannabis; HIV Infections; Humans; Marijuana Use; Methamphetamine; Neurocognitive Disorders | 2020 |
9 other study(ies) available for methamphetamine and Clerambault Syndrome
| Article | Year |
|---|---|
Methamphetamine augments HIV-1 gp120 inhibition of synaptic transmission and plasticity in rat hippocampal slices: Implications for methamphetamine exacerbation of HIV-associated neurocognitive disorders.
Topics: Animals; Glycoproteins; Hippocampus; HIV Infections; HIV-1; Humans; Long-Term Potentiation; Male; Methamphetamine; Neurocognitive Disorders; Neuronal Plasticity; Rats; Synaptic Transmission | 2022 |
Novel RNA-Seq Signatures Post-Methamphetamine and Oxycodone Use in a Model of HIV-Associated Neurocognitive Disorders.
Topics: Animals; HIV Infections; HIV-1; Humans; Methamphetamine; Neurocognitive Disorders; Oxycodone; RNA-Seq | 2023 |
Sustained attention and vigilance deficits associated with HIV and a history of methamphetamine dependence.
Topics: Adult; Amphetamine-Related Disorders; Attention; Central Nervous System Stimulants; Cognition; Female; HIV Infections; Humans; Male; Methamphetamine; Middle Aged; Neurocognitive Disorders; Reaction Time; Viral Load; Young Adult | 2020 |
Methamphetamine Increases the Proportion of SIV-Infected Microglia/Macrophages, Alters Metabolic Pathways, and Elevates Cell Death Pathways: A Single-Cell Analysis.
Topics: Animals; Biomarkers; Cell Death; Computational Biology; Gene Expression Profiling; High-Throughput Nucleotide Sequencing; Inflammation Mediators; Macaca mulatta; Macrophages; Metabolic Networks and Pathways; Methamphetamine; Microglia; Neurocognitive Disorders; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Single-Cell Analysis; Viral Load | 2020 |
Neurocognitive Profiles of Methamphetamine Users: Comparison of Those With or Without Concomitant Ketamine Use.
Topics: Adult; Amphetamine-Related Disorders; Analgesics; Analysis of Variance; Central Nervous System Stimulants; Drug Therapy, Combination; Executive Function; Female; Humans; Impulsive Behavior; Ketamine; Male; Methamphetamine; Middle Aged; Neurocognitive Disorders; Neuropsychological Tests; Taiwan; Young Adult | 2015 |
Mitochondrial injury and cognitive function in HIV infection and methamphetamine use.
Topics: Adult; Brain; Central Nervous System Stimulants; Cognition; Cohort Studies; DNA, Mitochondrial; HIV Infections; Humans; Male; Methamphetamine; Middle Aged; Mitochondria; Neurocognitive Disorders; Polymerase Chain Reaction; Substance-Related Disorders | 2016 |
Conditioned drug effects of pimozide, haloperidol and chlorpromazine on methamphetamine-induced behavior.
Topics: Animals; Arousal; Chlorpromazine; Conditioning, Classical; Disease Models, Animal; Dose-Response Relationship, Drug; Haloperidol; Male; Methamphetamine; Motor Activity; Neurocognitive Disorders; Orientation; Pimozide; Rats; Rats, Inbred Strains; Schizophrenic Psychology; Stereotyped Behavior | 1990 |
Enhancing effects of sound on methamphetamine-induced behavioral aberrations in the rat: a model of relapse of schizophrenia-like symptoms.
Topics: Acoustic Stimulation; Animals; Arousal; Association Learning; Behavior, Animal; Conditioning, Classical; Disease Models, Animal; Male; Methamphetamine; Motor Activity; Neurocognitive Disorders; Orientation; Rats; Rats, Inbred Strains; Schizophrenic Psychology; Stereotyped Behavior | 1990 |
Experimental geriatrics. Selection and prediction of therapeutic responsiveness in geriatric patients.
Topics: Aged; Amobarbital; Analysis of Variance; Carbon Dioxide; Hospitalization; Humans; Methamphetamine; Neurocognitive Disorders; Paranoid Disorders; Psychiatric Status Rating Scales; Psychological Tests; Psychotic Disorders; Schizophrenia | 1968 |